Safety and Efficacy of Adding Nalbuphine to Bupivacaine in Transversus Abdominis Plane Block in Laparoscopic Bariatric Surgery: A Randomised Controlled Trial. - Trial PACTR202208575341765
Access comprehensive clinical trial information for PACTR202208575341765 through Pure Global AI's free database. This Phase 3 trial is sponsored by Cairo University Hospitals and is currently Not yet recruiting. The study focuses on Surgery; Anaesthesia.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Cairo University Hospitals
ATEF KAMEL
Timeline & Enrollment
Phase 3
Apr 01, 2023
Jan 01, 1900
Summary
Bariatric surgery is increasing, analgesia is an integral part of anesthetic practice, TAP block provides adequate analgesia; however for limited time.we expect that addition of nalbuphine will prolong and improve the analgesic profileTo determine the effects of nalbuphine addition to bupivacaine on the analgesic profile.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR202208575341765
Non-Device Trial